Perspectives on the past, present, and future of cancer nanomedicine
- 1 May 2018
- journal article
- conference paper
- Published by Elsevier BV in Advanced Drug Delivery Reviews
- Vol. 130, 3-11
- https://doi.org/10.1016/j.addr.2018.05.008
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Science and ICT (2017R1A2B2004955)
This publication has 95 references indexed in Scilit:
- Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein deliveryAdvanced Drug Delivery Reviews, 2012
- Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent mannerNature Nanotechnology, 2012
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Drug targeting and tumor heterogeneityJournal of Controlled Release, 2008
- Tumor pH-responsive flower-like micelles of poly(l-lactic acid)-b-poly(ethylene glycol)-b-poly(l-histidine)Journal of Controlled Release, 2007
- Effect of Vascular Normalization by Antiangiogenic Therapy on Interstitial Hypertension, Peritumor Edema, and Lymphatic Metastasis: Insights from a Mathematical ModelCancer Research, 2007
- Pharmacokinetics of Pegylated Liposomal DoxorubicinClinical Pharmacokinetics, 2003
- The mechanism of 67Ga localization in malignant diseaseNuclear Medicine and Biology, 1996
- Isolation of a biotin receptor from hepatic plasma membranesBiochemical and Biophysical Research Communications, 1987
- Diffusion of univalent ions across the lamellae of swollen phospholipidsJournal of Molecular Biology, 1965